BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16403675)

  • 21. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.
    Pantaleo G; Menzo S; Vaccarezza M; Graziosi C; Cohen OJ; Demarest JF; Montefiori D; Orenstein JM; Fox C; Schrager LK
    N Engl J Med; 1995 Jan; 332(4):209-16. PubMed ID: 7808486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART.
    Marziali M; De Santis W; Carello R; Leti W; Esposito A; Isgrò A; Fimiani C; Sirianni MC; Mezzaroma I; Aiuti F
    AIDS; 2006 Oct; 20(16):2033-41. PubMed ID: 17053349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
    Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
    Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease.
    Lepej SZ; Begovac J; Vince A
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):351-9. PubMed ID: 16553807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma adenosine deaminase activity among HIV1 Clade C seropositives: relation to CD4 T cell population and antiretroviral therapy.
    Chittiprol S; Satishchandra P; Bhimasenarao RS; Rangaswamy GR; Sureshbabu SV; Subbakrishna DK; Satish KS; Desai A; Ravi V; Shetty KT
    Clin Chim Acta; 2007 Feb; 377(1-2):133-7. PubMed ID: 17049340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal analysis of T-cell receptor variable beta chain repertoire in patients with acute graft-versus-host disease after allogeneic stem cell transplantation.
    Liu C; He M; Rooney B; Kepler TB; Chao NJ
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):335-45. PubMed ID: 16503503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
    J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of detectable viremia in a perinatally HIV-1-infected teenager after discontinuation of antiretroviral therapy.
    Feeney ME; Tang Y; Rathod A; Kneut C; McIntosh K
    J Allergy Clin Immunol; 2006 Aug; 118(2):324-30. PubMed ID: 16890753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High IL-7 plasma levels may induce and predict the emergence of HIV-1 virulent strains in pediatric infection.
    Kopka J; Mecikovsky D; Aulicino PC; Mangano AM; Rocco CA; Bologna R; Sen L
    J Clin Virol; 2005 Jul; 33(3):237-42. PubMed ID: 15911446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [T cell receptor diversity of CD8+ T lymphocytes and its association with viral load in individuals with HIV-1 infection].
    Ren GL; Chen JP; Jia MM; Kou ZC; Liu S; Ma PF; Shao YM; Hong KX
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 May; 43(5):404-8. PubMed ID: 19534995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.
    Carr JM; Cheney KM; Coolen C; Davis A; Shaw D; Ferguson W; Chang G; Higgins G; Burrell C; Li P
    J Clin Microbiol; 2007 Apr; 45(4):1288-97. PubMed ID: 17314225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depletion of natural killer cells in the colonic lamina propria of viraemic HIV-1-infected individuals.
    Mela CM; Steel A; Lindsay J; Gazzard BG; Gotch FM; Goodier MR
    AIDS; 2007 Oct; 21(16):2177-82. PubMed ID: 18090044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
    Huttner AC; Kaufmann GR; Battegay M; Weber R; Opravil M
    AIDS; 2007 May; 21(8):939-46. PubMed ID: 17457087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
    Ruiz L; Paredes R; Gómez G; Romeu J; Domingo P; Pérez-Alvarez N; Tambussi G; Llibre JM; Martínez-Picado J; Vidal F; Fumaz CR; Clotet B;
    AIDS; 2007 Jan; 21(2):169-78. PubMed ID: 17197807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
    Theze J
    Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4(+) cell count increase predicts clinical benefits in patients with advanced HIV disease and persistent viremia after 1 year of combination antiretroviral therapy.
    Loutfy MR; Walmsley SL; Mullin CM; Perez G; Neaton JD; ;
    J Infect Dis; 2005 Oct; 192(8):1407-11. PubMed ID: 16170758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapy.
    Kostense S; Raaphorst FM; Notermans DW; Joling J; Hooibrink B; Pakker NG; Danner SA; Teale JM; Miedema F
    AIDS; 1998 Dec; 12(18):F235-40. PubMed ID: 9875570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.